Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
09/2012
09/26/2012EP2501696A2 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
09/26/2012EP2501691A1 Substituted pyrrolidine-2-carboxamides
09/26/2012EP2501678A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN102695704A Indole derivatives and methods for antiviral treatment
09/26/2012CN102690247A Furan compound, preparation method and application of same
09/26/2012CN102690239A Synthesis method of 1, 5-benzodiazepine derivative
09/26/2012CN102688234A Synthesis of indolone derivative as RSK2 inhibitor and application
09/26/2012CN102082230B Infrared organic electroluminescent device
09/26/2012CN102002037B Triphenylamine compound and application thereof
09/26/2012CN101611015B Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
09/25/2012US8274213 Electrochromic materials and electrochromic devices using the same
09/25/2012US8273767 Bicyclic-substituted amines as histamine-3 receptor ligands
09/25/2012US8273747 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin
09/25/2012US8273734 5HT2C receptor modulators
09/25/2012US8273733 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
09/25/2012CA2530983C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
09/20/2012WO2012124825A1 Sulfonamide compounds having trpm8 antagonistic activity
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012123471A1 Thiazole and thiophene compounds
09/20/2012WO2012123467A1 Pyrimidine amide compounds
09/20/2012WO2012123409A1 N-(1,2,5-oxadiazol-3-yl)-, n-(tetrazol-5-yl)- and n-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238574 (1, 1, 1,3,3,3 -hexafluoro-2 hydroxypropan- 2 -yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
09/20/2012US20120238569 Thiazole and thiophene compounds
09/20/2012US20120238550 Compound
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120234721 Diuretic and diuretic-like compound analogs
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830089A1 N-(1,2,5-oxadiazol-3-yl)-, n-(tetrazol-5-yl)- and n-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides
09/20/2012CA2826678A1 Sulfonamide compounds having trpm8 antagonistic activity
09/19/2012EP2500342A1 1-heterodiene derivative and noxious organism control agent
09/19/2012EP2500340A1 2-Cyanophenyl Sulfonamide Derivatives Useful as Pesticides
09/19/2012EP2499121A1 Oxazoline derivatives for treatment of cns disorders.
09/19/2012CN102686577A Compounds as tyrosine kinase modulators
09/19/2012CN102686572A Oxazoline derivatives for treatment of CNS disorders
09/19/2012CN102675300A Lipoic acid-aporphine conjugated compound, medicine composite and usage thereof
09/19/2012CN102675299A Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate
09/19/2012CN102675279A Thiophene analogues for the treatment or prevention of flavivirus infections
09/19/2012CN102675278A Preparation of photoelectric materials
09/19/2012CN102675229A Preparation method for 2,5-dimethylpyrazine derivative
09/19/2012CN102675211A Synthetization of secnidazole cinnamate derivative, and applications of secnidazole cinnamate derivative on antibacterial agent
09/18/2012USRE43676 Alkyl ether derivatives or salts thereof
09/18/2012US8269014 Thiophene analogues for the treatment or prevention of flavivirus infections
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268809 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
09/18/2012US8268459 Benzanthracene compound and organic electroluminescence device using the same
09/18/2012CA2273083C Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/13/2012WO2012122340A1 Soluble guanylate cyclase activators
09/13/2012WO2012122171A1 Herbicidal bis-nitrogen-containing oxo heterocycles
09/13/2012WO2012121992A1 Mst1 kinase inhibitors and methods of their use
09/13/2012WO2012121561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/13/2012WO2012121168A1 Kinase inhibitor
09/13/2012WO2012121101A1 Organic electroluminescence element
09/13/2012WO2012120428A1 Novel kinase inhibitors
09/13/2012WO2012120195A1 New pyridazinone and pyridone compounds
09/13/2012WO2012119978A1 Quinolinone derivatives
09/13/2012WO2012119551A1 Photoelectric material preparation
09/13/2012WO2012087182A3 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
09/13/2012WO2012074437A3 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
09/13/2012US20120232270 Heteroaromatic phthalonitriles
09/13/2012US20120232104 Novel sulfonamides as l-cpt1 inhibitors
09/13/2012US20120232094 Use of adrenergic n-phenylpiperazine antagonists, pharmaceutical compositions containing them, and methods of preparing them
09/13/2012US20120232070 Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease
09/13/2012US20120232064 Aspartyl protease inhibitors
09/13/2012US20120232053 Quaternary ammonium compounds useful as muscarinic receptor antagonists
09/13/2012US20120232019 Compositions and Methods for Treatment of Eye Disorders
09/13/2012US20120231017 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120228554 Materials for organic electroluminescent devices
09/13/2012DE10205367B4 Verbindung mit Phenylacetylenstruktur, Flüssigkristallzusammensetzung, Polymer und ihre Verwendung in einem optisch anisotropen Produkt oder einem optischen oder einem Flüssigkristall-Element Compound with Phenylacetylenstruktur, liquid crystal composition, polymer and their use in an optically anisotropic product, or an optical or a liquid crystal element
09/13/2012CA2832377A1 New pyridazinone and pyridone compounds
09/13/2012CA2830706A1 Quinolinone derivatives
09/13/2012CA2828578A1 Mst1 kinase inhibitors and methods of their use
09/12/2012EP2496558A1 Thetrahydroquinolines derivatives as bromodomain inhibitors
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102666490A Aminopyridine compound
09/12/2012CN102666485A Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
09/12/2012CN102660253A Pyrazoline derivative Ni<2+> fluorescence probe and application thereof
09/12/2012CN102659770A Double tetrathiofulvene compound containing pyridyl and preparation method thereof
09/12/2012CN102659769A Pyridine-containing TTF (tetrathiafulvalene) derivative and preparation method thereof
09/12/2012CN102659768A Preparation method for diaryl heterocyclic hexafluorocyclopentene class photochromic compounds
09/12/2012CN102659764A Tyrosine kinase inreversible inhibitor, its preparation method and application
09/12/2012CN102659658A Method for synthesis of highly functionalized pyrrole compound
09/12/2012CN101405347B Organic compound, semiconductor thin film electrode using the same, photoelectric transducer, and photoelectrochemical solar cell
09/11/2012US8263788 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
09/11/2012US8263787 Process for preparing dorzolamide
09/11/2012CA2445159C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
09/07/2012WO2012118715A2 Non-peptidic quenched fluorescent imaging probes
09/07/2012WO2012118498A1 Compounds and methods for the treatment of pain and other disorders
09/07/2012WO2012117421A1 Histone deacetylase inhibitors
09/07/2012WO2012117216A1 N- (arylalkyl) - 1h- indole- 2 - sulfonic acid amide compounds and their therapeutic use as cannabinoid allosteric modulators
09/07/2012WO2012117001A1 Novel benzodioxole piperidine compounds
09/07/2012WO2012116666A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof
09/07/2012WO2012116452A1 Antimicrobial/adjuvant compounds and methods
09/07/2012WO2011092226A8 Synthesis of substituted pyrazoline carboxamidine derivatives
09/07/2012CA2828831A1 Compounds and methods for the treatment of pain and other disorders
09/07/2012CA2828748A1 Antimicrobial / adjuvant compounds and methods
09/07/2012CA2823480A1 Novel benzodioxole piperidine compounds
09/06/2012US20120225909 Indazole analog
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 523